\-\ Texto\\:\\ \ \(0\)\
\-\ not\\ available\ \(73\)\
\-\ chemotherapy\ \(327\)\
\-\ 3\\ cm\\ suprasellar\\ mass\\ with\\ homogeneous\\ enhancement\\.\ \(1\)\
\-\ abnormal\\ appearance\\ of\\ white\\ matter\\ in\\ pons\\,\\ midbrain\\,\\ basal\\ ganglia\\ and\\ internal\\ capsules\\.\ \(0\)\
\-\ suprasellar\\ large\\ cell\\ lymphoma\\,\\ of\\ the\\ b\\-cell\\ phenotype\\ \\(cd20\\ positive\\)\\.\ \(0\)\
\-\ \\â\\€\\¢\\ metastatic\\ disease\ \(13\)\
\-\ \\â\\€\\¢\\ meningioma\ \(7\)\
\-\ \\â\\€\\¢\\ macroadenoma\\ of\\ pituitary\\ gland\ \(0\)\
\-\ \\â\\€\\¢\\ sarcoid\ \(3\)\
\-\ \\â\\€\\¢\\ lymphoma\\,\\ germinoma\\,\\ syphilis\ \(0\)\
\-\ 60\\ year\\ oldwoman\\ with\\ 5\\ year\\ history\\ of\\ stage\\ iv\\ follicular\\ type\\ b\\ cell\\ lymphoma\\ presents\\ now\\ with\\ visual\\ symptoms\\ and\\ headache\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ suprasellar\\:\\ 0\\.11357647172211771\ \(0\)\
\-\ oldwoman\\:\\ 0\\.10750632224349388\ \(0\)\
\-\ \\â\\€\\¢\\:\\ 0\\.0955496555851151\ \(0\)\
\-\ lymphoma\\:\\ 0\\.0893487305264446\ \(0\)\
\-\ phenotype\\:\\ 0\\.08787903062844388\ \(0\)\
\-\ capsules\\:\\ 0\\.08565559700900541\ \(0\)\
\-\ cd20\\:\\ 0\\.0837757106696486\ \(0\)\
\-\ germinoma\\:\\ 0\\.07369426465520386\ \(0\)\
\-\ syphilis\\:\\ 0\\.06981068256839247\ \(0\)\
\-\ macroadenoma\\:\\ 0\\.06874956821486039\ \(0\)\
\-\ follicular\\:\\ 0\\.06874956821486039\ \(0\)\
\-\ midbrain\\:\\ 0\\.06562842950587015\ \(0\)\
\-\ b\\-cell\\:\\ 0\\.064865986128049\ \(0\)\
\-\ pons\\:\\ 0\\.05955722916148991\ \(0\)\
\-\ cell\\:\\ 0\\.05629855394101186\ \(0\)\
\-\ sarcoid\\:\\ 0\\.05347197103808761\ \(0\)\
\-\ ganglia\\:\\ 0\\.053327648383855876\ \(0\)\
\-\ pituitary\\:\\ 0\\.052230718668454176\ \(0\)\
\-\ homogeneous\\:\\ 0\\.04932724145732724\ \(0\)\
\-\ b\\:\\ 0\\.049122276599810395\ \(0\)\
\-\ basal\\:\\ 0\\.047506554855346016\ \(0\)\
\-\ visual\\:\\ 0\\.047242390260453584\ \(0\)\
\-\ 60\\:\\ 0\\.04546246449675749\ \(0\)\
\-\ stage\\:\\ 0\\.04445163937717496\ \(0\)\
\-\ gland\\:\\ 0\\.04438254501698377\ \(0\)\
\-\ matter\\:\\ 0\\.041030243541473145\ \(0\)\
\-\ meningioma\\:\\ 0\\.040074260200671646\ \(0\)\
\-\ iv\\:\\ 0\\.03802957240806212\ \(0\)\
\-\ chemotherapy\\:\\ 0\\.03735299737976665\ \(0\)\
\-\ headache\\:\\ 0\\.03579250533616827\ \(0\)\
\-\ now\\:\\ 0\\.03562336085002009\ \(0\)\
\-\ type\\:\\ 0\\.03512956376032818\ \(0\)\
\-\ available\\:\\ 0\\.03503315913219265\ \(0\)\
\-\ internal\\:\\ 0\\.034937510626570384\ \(0\)\
\-\ white\\:\\ 0\\.03456224649648802\ \(0\)\
\-\ positive\\:\\ 0\\.03381567793029411\ \(0\)\
\-\ 5\\:\\ 0\\.030489761249319066\ \(0\)\
\-\ appearance\\:\\ 0\\.02980373874066636\ \(0\)\
\-\ abnormal\\:\\ 0\\.029720637077011114\ \(0\)\
\-\ cm\\:\\ 0\\.02795068436362178\ \(0\)\
\-\ enhancement\\:\\ 0\\.02793278983076873\ \(0\)\
\-\ metastatic\\:\\ 0\\.026233041507513297\ \(0\)\
\-\ symptoms\\:\\ 0\\.025971432645099258\ \(0\)\
\-\ 3\\:\\ 0\\.02440214056959195\ \(0\)\
\-\ year\\:\\ 0\\.023319640713973532\ \(0\)\
\-\ large\\:\\ 0\\.02278710282720829\ \(0\)\
\-\ presents\\:\\ 0\\.02128834506716983\ \(0\)\
\-\ disease\\:\\ 0\\.017033384648972003\ \(0\)\
\-\ \\,\\:\\ 0\\.01650671131202972\ \(0\)\
\-\ not\\:\\ 0\\.015058764289535799\ \(0\)\
\-\ mass\\:\\ 0\\.01449342691399469\ \(0\)\
\-\ history\\:\\ 0\\.014392860215940042\ \(0\)\
\-\ \\(\\:\\ 0\\.008809289344437324\ \(0\)\
\-\ \\)\\:\\ 0\\.008701679172113477\ \(0\)\
\-\ of\\:\\ 0\\.005683112234048216\ \(0\)\
\-\ in\\:\\ 0\\.005138990611466524\ \(0\)\
\-\ and\\:\\ 0\\.004390463554444352\ \(0\)\
\-\ with\\:\\ 0\\.004280640588654502\ \(0\)\
\-\ \\.\\:\\ 0\\.0017316846876754281\ \(0\)\
\-\ the\\:\\ 0\\.001685966886629583\ \(0\)\
